METASTATIC MEDULLOBLASTOMA - THE EXPERIENCE OF THE FRENCH COOPERATIVE M7 GROUP

被引：27

作者：

BOUFFET, E

GENTET, JC

DOZ, F

TRON, P

ROCHE, H

PLANTAZ, D

THYSS, A

STEPHAN, JL

LASSET, C

CARRIE, C

ALAPETITE, C

CHOUX, M

MOTTOLESE, C

VISOT, A

ZUCKER, JM

BRUNATMENTIGNY, M

BERNARD, JL

机构：

[1] HOP ENFANTS LA TIMONE, DEPT PAEDIAT ONCOL, MARSEILLE, FRANCE

[2] INST CURIE, DEPT PAEDIAT ONCOL, PARIS, FRANCE

[3] HOP CHARLES NICOLLE, DEPT PAEDIAT ONCOL, ROUEN, FRANCE

[4] CTR CLAUDIUS REGAUD, DEPT PAEDIAT ONCOL, TOULOUSE, FRANCE

[5] HOP TRONCHE, DEPT PAEDIAT ONCOL, GRENOBLE, FRANCE

[6] CTR ANTOINE LACASSAGNE, DEPT PAEDIAT ONCOL, NICE, FRANCE

[7] HOP NORD ST ETIENNE, DEPT PAEDIAT ONCOL, ST ETIENNE, FRANCE

[8] HOP ENFANTS LA TIMONE, DEPT PAEDIAT NEUROSURG, MARSEILLE, FRANCE

[9] HOP WERTHEIMER, DEPT PAEDIAT NEUROSURG, LYON, FRANCE

[10] HOP TROUSSEAU, DEPT PAEDIAT NEUROSURG, PARIS, FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 10期

关键词：

MEDULLOBLASTOMA; METASTATIC DISEASE; CHEMOTHERAPY; RADIOTHERAPY; PROGNOSTIC FACTORS;

D O I：

10.1016/0959-8049(94)00256-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A retrospective analysis was performed to determine the outcome of children with metastatic medulloblastoma given a standardised treatment programme. Of 68 consecutive patients treated in the French M7 protocol for medulloblastoma, 23 presented with metastatic disease. They were uniformly treated with surgery, and the same protocol of chemotherapy and craniospinal radiotherapy. The 7-year relapse-free survival rate is 43% for metastatic patients compared to 68% for patients with localised disease. Survival did not correlate with age, sex, location of metastases, extent of initial surgery and the dose of radiation therapy on the posterior fossa. Survival did correlate with the dose to the cranial field with a threshold dose of 30 Gy. Patients with metastatic disease have a worse prognosis and require more aggressive therapies at initial presentation. The prognostic impact of the different sites of metastatic disease requires further evaluation in cooperative studies.

引用

页码：1478 / 1483

页数：6

共 23 条

[1] RADIATION TREATMENT FOR MEDULLOBLASTOMA - A 21-YEAR REVIEW [J].

BERRY, MP ;

DEREK, R ;

JENKIN, T ;

KEEN, CW ;

NAIR, BD ;

SIMPSON, WJ .

JOURNAL OF NEUROSURGERY, 1981, 55 (01) :43-51

[2]

BLOOM HJG, 1981, 13 P M INT SOC PAED

[3] QUALITY-CONTROL OF RADIOTHERAPEUTIC TREATMENT OF MEDULLOBLASTOMA IN A MULTICENTRIC STUDY - THE CONTRIBUTION OF RADIOTHERAPY TECHNIQUE TO TUMOR RELAPSE [J].

CARRIE, C ;

ALAPETITE, C ;

MERE, P ;

AIMARD, L ;

PONS, A ;

KOLODIE, H ;

SENG, S ;

LAGRANGE, JL ;

PONTVERT, D ;

PIGNON, T ;

LACROZE, M ;

GINESTET, C ;

BERNARD, JL .

RADIOTHERAPY AND ONCOLOGY, 1992, 24 (02) :77-81

[4] AN OPERATIVE STAGING SYSTEM AND A MEGAVOLTAGE RADIOTHERAPEUTIC TECHNIC FOR CEREBELLAR MEDULLOBLASTOMAS [J].

CHANG, CH ;

HOUSEPIAN, EM ;

HERBERT, C .

RADIOLOGY, 1969, 93 (06) :1351-+

[5]

CHASTAGNER P, 1988, ARCH FR PEDIATR, V45, P249

[6]

DEUTSCH M, 1985, CANCER, V56, P1763, DOI 10.1002/1097-0142(19851001)56:7+<1763::AID-CNCR2820561306>3.0.CO

[7]

2-6

[8] THE IMPACT OF MYELOGRAPHY ON THE TREATMENT RESULTS FOR MEDULLOBLASTOMA [J].

DEUTSCH, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (07) :999-1003

[9]

DEUTSCH TP, 1992, P AN M AM SOC CLIN, V10, P124

[10] THE TREATMENT OF MEDULLOBLASTOMA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL OF RADIATION-THERAPY WITH AND WITHOUT CCNU, VINCRISTINE, AND PREDNISONE [J].

EVANS, AE ;

JENKIN, RDT ;

SPOSTO, R ;

ORTEGA, JA ;

WILSON, CB ;

WARA, W ;

ERTEL, IJ ;

KRAMER, S ;

CHANG, CH ;

LEIKIN, SL ;

HAMMOND, GD .

JOURNAL OF NEUROSURGERY, 1990, 72 (04) :572-582

← 1 2 3 →